The two-year project was carried out thanks to co-funding of approximately €3 million from the European Commission through the EU for Health (EU4H) program. The main results achieved were presented during the final meeting, held at the ISS headquarters, and summarized in a video shared on the Institute's social media channels. These results included defining evaluation criteria for the network's sequencing activities, enhancing the data management platform, reviewing sequencing strategies, and assessing the laboratories' current capacity to sequence the SARS-CoV-2, influenza, and RSV viruses. An analysis of the laboratory network's long-term sustainability was also conducted, and new mathematical models were developed to predict the impact of new variants on the epidemiology of SARS-CoV-2.
